Cite
APA Citation
Schwarzbich, M., Schöning, T., Cremer, M., Lisenko, K., Ho, A. D., & Witzens-Harig, M. (n.d.). efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment. Leukemia & lymphoma, 57(7), 1723–1726. http://access.bl.uk/ark:/81055/vdc_100034281920.0x000052